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ABSTRACT 
This thesis concerns some mechanistic properties of the basic helix-loop-helix/PAS 
(bHLH-PAS) factors aryl hydrocarbon receptor (AhR) and hypoxia-inducible factor 1 
alpha (HIF-1α). The bHLH-PAS family of proteins is a family of factors that controls a 
variety of developmental and physiological events. A common feature for this family of 
proteins is that they act mainly as intracellular transcription factors. They bind to DNA 
as a heterodimeric complex, usually together with a bHLH-PAS protein belonging to 
the aryl hydrocarbon receptor nuclear translocator (ARNT) subfamily. The AhR bind 
ligands that are environmental pollutants, as well as possibly physiological compounds 
occurring in the diet. Known functions of the ligand-activated AhR include activation of 
genes involved in xenobiotic metabolism and an ubiquitin ligase activity targeting 
nuclear receptors (such as the estrogen receptor) and beta-catenin. HIF-1α mediates 
signal transduction and gene regulation in cells exposed to deprived oxygen conditions 
(hypoxia). 
In paper I, we have shown that the Ah-receptor can be activated by stimulus other than 
xenobiotics, e.g dioxin. AhR is recruited to target genes in both ligand treated and in 
suspension culture, suggesting a common mechanism of activation between these two 
routes of AhR activation. The gene expression profiles critically differ between 
xenobiotic and suspension activated AhR signaling. The classical xenobiotic 
metabolizing AhR targets such as Cyp 1a1, Cyp 1b1 and Nqo were regulated by both 
ligand and suspension conditions. Sequence analysis coupled with ChIP assays and 
reporter gene analysis identified a functional xenobiotic response element (XRE) within 
the mouse TIPARP gene that features a concatamer of 4 XRE cores residing in the first 
intron. 
In paper II we have shown that ectopic expression of ARNT, in mammalian cells and 
yeast cells, was sufficient to promote nuclear accumulation of the Ah-receptor in a 
ligand-independent manner. We further observed that overexpression of ARNT 
promotes derepression of Ah-receptor function in the absence of ligand, thereby 
possibly representing an alternative mechanism of activation that is distinct from 
activation by xenobiotic ligands and thus may be of physiological relevance. We also 
describe that an excess of ARNT in relation to the Ah-receptor and HIF-1α promotes 
derepression of the receptor and stabilization of HIF-1α in vivo and in vitro, 
representing a possible alternative mechanism of activation of bHLH-PAS proteins. 
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INTRODUCTION 
 
Aryl hydrocarbon receptor (AhR) signaling 
 
Industrial processes and organic combustion are sources for polycyclic aromatic 
hydrocarbons. One such polycyclic aromatic hydrocarbon is the deadly poison dioxin, 
i.e. 2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD (Figure 1). Diet, skin contact or 
inhalation can expose animals and humans to these compounds. Endogenous molecules 
with structural similarity to these compounds exist, e.g. indolo compunds (flavonoids, 
indigoids and derivatives of the indole-3-carbinole). Events of occupational and 
accidental exposure to polycyclic aromatic hydrocarbons (PAHs) are a source of 
environmental and public health concern. The half-life of dioxin in humans is about 
seven years, illustrating that it represents a persistent environmental contaminant. One 
important structural feature is shared among aryl hydrocarbon receptor (AhR) ligands: 
planarity, or the ability to become co-planar (Gillner et al., 1993). Responses to these 
molecules, e.g. dioxin, beta-naphtoflavone, and 3-methyl–cholanthrene (3MC), can be 
both adaptive and toxic (Cespedes et al., 2010). The liver produces xenobiotic 
metabolizing enzymes in response to many of these compounds. The enzymes include 
the P450 family, a family of drug metabolizing enzymes. Dioxins are difficult to 
metabolize and they often provoke an additional battery of toxic responses; these 
include recalcitrant acne (chloracne), tumor promotion, thymic involution, wasting and 
death (Mimura and Fujii-Kuriyama, 2003). The recalcitrant chloracne is the result of 
hyperkeratinization and metaplasia of hair follicles and interfollicular epidermis 
followed by formation of cysts and abscesses (Suskind, 1985; Zugerman, 1990). The 
lesions can persist for 30 years after severe exposure to polychlorinated hydrocarbons 
(Moses and Prioleau, 1985). 
 
 
 
 
 
FIGURE 1. Chemical structure of dioxin or 2,3,7,8 tetrachlorodibenzo-p-dioxin 
(TCDD).  
 
 
 
The AhR binds PAHs and functions as a ligand-activated transcription factor. Ligand 
binding increases nuclear accumulation of the AhR receptor via a process presumed to 
involve structural transformation and/or nuclear localization signal presentation  
(Kazlauskas et al., 2000). Once in the nucleus, the PAS domain of AhR mediates 
dimerization with the corresponding PAS domain of a constitutively nuclear protein 
known as ARNT (Figure 2). This complex binds xenobiotic response elements (XREs) 
of target genes and recruits several coregulatory proteins, including NCOA1 and 
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NCOA3, p300 (Lee et al., 2000) and the general transcription factor transcription factor 
IIB (TFIIB) that is required for transcriptional initiation by RNA polymerase II 
(Beischlag et al., 2002; Hankinson, 2005). 
 
 
 
 
 
FIGURE 2. A schematic model of the AhR signaling and degradation pathways. 
The AhR is both a ligand-activated transcription factor and a ligand-dependent ubiquitin E3 
ligase targeting itself and substrate proteins such as steroid receptors and β-catenin for 
proteasomal degradation. Upon ligand activation the receptor translocates from the cytosol to 
the nucleus, disassociates from hsp90 and dimerizes with the partner factor ARNT. 
Subsequently, the AhR/ARNT complex binds to xenobiotic response elements (XREs) in the 
promoter of target genes such as CYP1A1 and AhRR. See text for details. 
 
 
The AhR belongs to the basic helix-loop-helix/PAS (bHLH-PAS) family of factors. 
PAS is an acronym based on the founding members of this family of proteins, i.e. in 
Drosophila, period (PER), single-minded protein (SIM), and mammalian ARNT. The 
functional architecture of the bHLH-PAS proteins is characterized by the N-terminally 
situated basic region, responsible for DNA binding, followed by the HLH domain, 
which, together with the PAS domain is important for dimerization specificity and 
stability (Figure 3). 
 
The AhR seems to have a limited set of target genes (please see below, Paper 1) but 
these genes include the drug metabolizing enzymes such as CYP1A1 that are induced 
by dioxin. The AhR also induces expression of an aryl hydrocarbon receptor repressor 
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(AhRR) - an inhibitor of AhR. The AhRR lacks a transactivation domain and works like 
a repressor: it dimerizes with ARNT and acts as a repressor through steric hindrance at 
the level of DNA binding and also through its endogenous transrepressor capacity 
(Evans et al., 2008). The repressor has three SUMOylation sites that are conserved 
across vertebrate species. All three sites must be SUMOylated for full suppressive 
activity (Oshima et al., 2009). Prolonged ligand-dependent activation of AhR induces 
its repressor to displace it and to actively repress its targets. The AhRR promoter has 
functional XRE sequences, and gene expression is enhanced upon ligand activation of 
AhR, resulting in the inhibition of AhR signaling activity (Baba et al., 2001; Mimura et 
al., 1999) 
 
 
 
FIGURE 3. Different members of the bHLH-PAS protein family.  
The basic-helix-loop-helix domain (bHLH) is depicted in green, with the PAS repeats in blue. 
The C-terminal region of these proteins is variable, often containing domains for transactivation 
or repression. ODDD is short for “oxygen dependent degradation domain” that can be found in 
the HIFs. 
 
 
In the absence of ligand the AhR is a cytoplasmic protein associated with chaperons 
and chaperonins: a dimer of hsp90 and p23 and the AhR associated protein, XAP2 (also 
known as AIP or ARA9). These chaperonins help the receptor fold correctly and 
maintain its location in the cytoplasm. The PAS B domain partly mediates interactions 
between the AhR and these proteins (Figure 2).  (Dolwick et al., 1993; Reyes et al., 
1992; Swanson and Bradfield, 1993)(Reyes, Reisz-Porszasz et al. 1992; Dolwick, 
Swanson et al. 1993; Swanson and Bradfield 1993) 
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Possible physiological functions of the AhR 
 
There is strong evidence that AhR plays significant roles in the immune system 
(Kerkvliet, 1995). Exposure to TCDD leads to severe thymic involution and profound 
suppression of both the humoral and cellular immune response, resulting in increased 
susceptibility to infection. In addition, AhR-mutant mice are defective in T-cell 
differentiation and are more susceptible to bacterial infection (Kerkvliet, 2009; Stevens 
et al., 2009). AhR null mice are also protected from the toxic effects of dioxins; 
treatment with these compounds does not cause birth defects (Peters et al., 1999) 
 
In the presence of ligand the AhR can form an E3 ubitquitin ligase complex with 
Cullin-4B (CUL4B), damaged DNA binding-1 (DDB1), transducin beta-like 3 (TBL3) 
and ringbox protein 1 (RBX1)/ROC and catalyze the ubiquitylation of the sex steroid 
hormone receptors, estrogen receptor-α (ER-α), estrogen receptor-β (ER-β), and the 
androgen receptor (AR), as well as AhR itself (Ohtake et al., 2007).  It was recently 
found that this complex also ubiquitylates β-catenin and functions as a tumor 
suppressor in the colon (Kawajiri et al., 2009). 
 
Hypoxia Signaling 
 
Our understanding of the molecular physiology of oxygen homeostasis and how it is 
regulated and dysregulated has increased dramatically during the last two decades. 
In the middle of the 1990’s the hypoxia inducible factor-1α (HIF-1α) was cloned as the 
protein that bound to the EPO enhancer together with its partner factor ARNT 
(Jelkmann and Hellwig-Burgel, 2001; Jiang et al., 1996). Additional components of the 
intracellular signaling mechanisms were subsequently characterized, and today we have 
a good understanding of the core signaling machinery that converts the hypoxic 
stimulus to gene regulatory events in the nucleus. 
 
Cellular functions of HIF 
 
HIF-1α is rapidly degraded under normoxic conditions and is stabilized in response to 
hypoxia. It was for long unknown what is the oxygen sensor. However, the 
observations that proline residues within the degradation domain of HIF-1α (termed 
ODDD, Figure 3) and the cloning of intracellular proline hydroxylases provided a 
stringent model of intracellular oxygen sensing (Bruick and McKnight, 2001; Epstein 
et al., 2001; Jaakkola et al., 2001; Mole et al., 2001). Under normoxic conditions the 
hydroxylated proline residues of HIF-1α are recognized by the VHL protein which 
functions as an E3 ubiquitin ligase (Figure 4). Cells deficient in functional VHL protein 
show constitutively high HIF-1α protein levels and constitutive expression of many 
oxygen-regulated genes. In VHL disease this leads to highly vascularized renal cancer 
and hemangioblastoma formation (Maxwell et al., 1999; Ohh et al., 2000; Tanimoto et 
al., 2000).  
 
  13 
 
 
 
FIGURE 4. The HIF signaling pathway. 
The HIF target genes all mediate adaptive responses to hypoxia e.g. EPO (erythropoietin), 
several glycolytic enzymes, VEGF (vascular endothelial growth factor). There are two proline 
residues in the oxygen dependent degradation domain that are hydroxylated by proline 
hydroxylases (PDHs) under normal oxygen conditions. The hydroxylated prolyl residues bind 
the von Hippel-Lindau protein (pVHL), leading to ubiquitination and subsequent proteasomal 
degradation. The stabilized HIF-α protein accumulates in the nucleus, interacts with ARNT, 
binds to hypoxia responsive elements (HREs) of target genes, and recruits coactivator proteins 
such as p300/CBP to increase gene transcription and mediate adaptive responses to hypoxia. 
 
 
In analogy to the AhR, HIF-1α interacts with the molecular chaperone hsp90 which 
helps HIF-1α to adapt and maintain the correct structure (Katschinski et al., 2004; Liu 
et al., 2007). Both the AhR and HIF-1α interact with hsp90 via the C-terminus of their 
bHLH-PAS domains (termed the PAS B domains, Figure 3).  
 
Hypoxia in physiology and pathology  
 
HIF plays a major role in normal development of an organism. HIF-deficient mice 
(knockout of HIF-1α or ARNT protein) show early lethal phenotypes (around day 
E8.5-10.5) with a collapsed vascular development (Carmeliet et al., 1998; Maltepe et 
al., 1997; Tian et al., 1998). HIF signaling plays a significant role in a number of 
pathophysiological settings, such as inflammation, cardiovascular diseases, tumor 
metabolism, stroke and tumor metastasis (Acker and Acker, 2004; Anagnostopoulos et 
al., 2008; Zinkernagel et al., 2007) 
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HIFs come in many different flavors 
 
There are a number of HIF paralogues: HIF-1α, -2α, -3α. HIF-3α is alternatively 
spliced to give rise to inhibitory PAS protein (IPAS) (Makino et al., 2001). IPAS lacks 
a trans-activating domain and functions as a negative regulator of HIF-1α. It is 
expressed in the cornea epithelium and plays a role in maintaining an avascular 
phenotype of this tissue. 
 
The physiological role of HIF-3α  still remains to be elucidated, however it has been 
shown that expression of HIF-3α during embryonic and neonatal stages is important for 
negative regulation of endothelin-1 expression since there is massive pulmonary 
hypertension and cardiac hypertrophy in HIF-3α-deficient mice (Yamashita et al., 
2008). At least five different splice variants may be expressed from the human HIF-3α 
locus that are suggested to exert primarily negative regulatory effects on hypoxic gene 
regulation (Tanaka et al., 2009). 
 
Hsp90 is known to bind HIF-1α , and hsp90 inhibitors have been shown to inhibit 
tumor growth and to induce proteasomal degradation of HIF-1α, even in cells lacking 
pVHL (Isaacs et al., 2002). RACK1 was shown to compete with hsp90 for binding to 
the PAS A – domain of HIF-1α. Treatment with an hsp90 inhibitor such as 
geldanamycin results in unopposed RACK1 binding leading to increased ubiquitination 
and degradation of HIF-1α. The ability of hsp90 inhibitors to induce HIF-1α 
degradation is dependent on RACK1 expression (Liu et al., 2007).  
 
ARNT - a master regulator of bHLH PAS proteins 
 
As outlined above, ARNT interacts with both HIF-1α and the. The ARNT protein is 
also capable of forming a homodimer with binding preference for the palindromic E-
box sequence, CACGTG (Swanson and Yang, 1999). It was recently shown, both in 
vitro and in vivo, that ARNT as a homodimer can regulate the CYP2a5 promoter 
(Arpiainen et al., 2007). The CYP2a5 was found to be important in murine primary 
hepatocytes, and is involved in degradation of bilirubin, a breakdown product of heme. 
The CYP2a5 is speculated to be involved in nicotine-degradation as well as 
nitrosamines and aflatoxins (Nakajima et al., 1996; Pelkonen et al., 1997). 
 
The tissue distribution of ARNT is ubiquitous. In contrast to HIF-1α and AhR, ARNT 
is not regulated by ligands or by hypoxia. There are several paralogues of ARNT: 
ARNT (= ARNT1), ARNT2, and ARNT3. Only ARNT and ARNT2 can dimerize with 
HIF-1α. The role, if any, of ARNT3 (MOP3) in hypoxia signaling is unclear. It has 
been shown that ARNT3 interacts with CLOCK to regulate circadian rhythms. Mice 
lacking ARNT3 show severe deficits in circadian rhythmicity (Cowden and Simon, 
2002). 
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AIM OF THE STUDY 
 
The aim of the study was to investigate if ligand-dependent activation of the AhR 
results in activation of different target genes in comparison to ligand-independent 
activation of AhR function upon loss of cell-cell contacts (suspension culture; Paper I). 
Possibly, this information could shed light on the physiological function of the AhR. 
Secondly, based on preliminary observations that an excess of ARNT induces nuclear 
accumulation of both the AhR and HIF-1α, we were interested in investigating whether 
ARNT can provide a mode of regulation of these proteins under conditions of no 
environmental pollution or hypoxic stress (Paper II). 
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METHODOLOGICAL CONSIDERATIONS 
 
Reconstitution of AhR function in Yeast 
Sacchromyces cerevisiae, or bakers yeast, is recognized as an ideal eukaryotic 
microorganism for biological studies. Despite the small genomic size, 1,4x107 bp, the 
haploid nuclear DNA content is only 3.5 times that of E. Coli, yeast displays most of 
the cellular house keeping features of higher eukaryotes. Many cellular processes, like 
cell cycle regulation and the basic transcriptional machinery are structurally and 
mechanistically conserved among different species. Some of the properties that make 
yeast particularly suitable for biological studies include rapid growth, the ease of 
replica plating and mutant isolation, and a highly versatile DNA transformation system. 
Plasmids can be introduced into yeast either as replicating molecules or by integration 
into the genome. We used yeast to study the activation of AhR by an excess of ARNT. 
Important is also the ability of certain ligands, in particular the dietary indole derivative 
indolo[3,2-b]carbazole to activate the AhR in S. cerevisiae  
 
Western blot 
Western blot or immunoblot is the golden standard of molecular biology methods to 
detect and identify specific proteins with antibodies. The first step at a western blot 
analysis is to purify the protein content from a cell or a tissue of interest. The proteins 
are then separated by SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis), together with a known molecular weight marker according to size. 
SDS binds and denatures proteins and make them negatively charged. Subsequently the 
proteins are transferred to a support, e.g. a membrane (most commonly a nylon or a 
nitrocellulose membrane). To check the quality of the transfer the membrane can be 
stained with Ponceau S solution staining proteins. To reduce nonspecific binding of 
antibodies the membrane is blocked with nonfat milk powder or bovine serum albumin. 
After the blocking the membrane is incubated with a primary antibody that recognizes 
the protein of interest. In order to detect the primary antibody, a second antibody 
coupled to an enzyme, directed against the primary antibody, is added. Finally a 
substrate for the conjugated enzyme is used to detect the protein. Even though the 
primary antibody is made for detection of a specific protein it is always a risk that the 
antibody will bind to other proteins. Both monoclonal and polyclonal antibodies can be 
used for Western blot analysis but monoclonal antibodies react only with one epitope 
and are considered to be more specific to the protein of interest. On the other hand, a 
good polyclonal antibody has higher sensitivity. Washing the membrane thoroughly 
after each antibody application is also important to avoid nonspecific binding of the 
antibodies. This is usually done with a phosphate or Tris buffer together with the 
detergent Tween 20. 
 
Quantitaive PCR 
Quantitative PCR is a method to measure a certain amount of DNA or RNA in cells or 
tissue. Most PCR methods amplify the template from minute starting materials, and end 
with measurable amounts. qPCR detection methods are based on changes in 
fluorescence, which are proportional to the amount of increased target (quantitative) 
and the process is measured as time goes, so called real-time PCR. RNA is a very labile 
molecule and does not survive the high temperature that is necessary for PCR run. 
Therefore the RNA has to be converted to cDNA by using reverse transcriptase. The 
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measurement can be done in two different ways, either by absolute measurement or by 
a ratio in relation to another gene, usually a gene that exists in most cell types (a 
housekeeping gene). Commonly used housekeeping genes are, glyceraldehydes-3-
phosphate dehydrogenase (GAPDH), β-actin, or hypoxanthine-guanine 
phosphoribosyltransferase (HPRT). To calculate how many copies of RNA or DNA 
that are in the starting material, a standard curve using material with already known 
amounts of cDNA or DNA has to be run parallel with the sample.  
 
Chromatin immunoprecipitation (ChIP) 
ChIP is a powerful method in connecting transcription factors, co-activators, repressors 
or DNA-modifications to a specific endogenous DNA sequence as well as for 
examining protein-DNA interactions at a genome-wide scale. The result is often very 
useful to postulate the function of a specific transcription factor or histone modification. 
Despite the excellent value of ChIP assay, it is important to be aware of the limitations. 
One big issue of the ChIP method is the antibody specificity and quality of different 
batches. Also blocking of epitopes caused by cross-linking and varying quality of 
chromatin fragmentation could affect the result of ChIP analysis. In brief, ChIP 
involves formaldehyde treatment of a cell population to cross-link proteins to their 
target DNA, cell lysis, sonication of the chromatin to 300-500 bp fragments, and then 
immunoprecipitation of specific protein/chromatin complexes using an antibody 
against the protein of interest. After removal of the cross-links, various methods of 
analysis of bound DNA can be used, e.g. PCR amplification, microarray or sequencing. 
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RESULTS AND DISCUSSION 
 
Paper I 
Even though the AhR was activated by different modes, i.e. by ligand treatment of 
upon loss of cell-cell contacts in suspension culture, a similar battery of AhR-specific 
target genes was induced. For instance, genes encoding drug metabolizing enzymes 
such as Cyp1A1 and Cyp1B1 and Nqo1 (NADPH- quinone oxidoreductase1) were 
induced in a similar fashion by both modes of activation. These genes represent 
classical already known AhR target genes. Interestingly, the identified AhR-specific 
battery of target genes remained relatively small even if the mode of AhR activation 
was switched to a ligand-independent mode. However, there were some subtle 
differences between the two modes of activation. Por (P450 cytochrome oxidase) and 
Cldnd 1 were regulated predominately by ligand treatment, while in contrast, ApoER2 
(Apolipoprotein E receptor 2) and Ganc (neutral alpha-glucoside C) were regulated 
predominately by the suspension condition. In addition to activation of AhR target 
genes, suspension culture induced (as expected) expression of a large number of target 
genes in an AhR-independent manner, presumably due to activation of other distinct 
signaling pathways. Tiparp (TCDD-inducible poly[ADP-ribose] polymerase) 
represents an AhR target gene that is not encoding a drug metabolizing enzyme but is 
induced in a similar fashion by the two different modes of receptor activation. 
Sequence analysis coupled with AhR chromatin immunoprecipitation (ChIP) assays 
and reporter gene analysis identified a functional XRE within the mouse Tiparp gene 
that features a concatamer of 4XRE cores residing in the first intron about 1.2 kb 
downstream of the Tiparp transcription start site. This work gives novel insights into 
how AhR signaling drives transcriptional programs via the ligand versus suspension 
modes of activation. 
 
Paper II  
In paper II we observed that AhR and HIF-1α function can be induced in the presence 
of high levels of ARNT. This is a novel finding and suggests a new way for ARNT to 
activate its partner factors HIF 1α and AhR in the absence of AhR ligand or hypoxia, 
respectively. Consistent with these observations, in the absence of AhR ligand and 
hypoxia, an excess of ARNT induced translocation of either AhR or HIF-1α from the 
cytoplasm to the nucleus, and stabilized HIF-1α from proteasomal degradation. As a 
negative control we used the delta basic-helix-loop-helix protein ARNT, which has 
been shown not to dimerize with the AhR, 
 
Derepression of AhR function by high levels of ARNT in yeast 
To further explore regulation of AhR function by ARNT we co-transformed yeast cells 
with high or low copy number vectors encoding mAhR, ARNT, or, as negative 
controls, the ARNT mutants ARNT delta basic or delta basic helix-loop-helix. We then 
monitored activation of AhR function in the absence or presence of AhR ligand. 
Expression levels of the constructs were monitored by Western blot analysis. We could 
see a clear pattern where full-length ARNT, but not the truncated versions, was 
activating AhR to a functional transcription factor in the absence ligand. 
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Derepression of AhR function and stabilization of HIF-1α  by high levels of ARNT in 
mammalian cells 
In the presence of an excess of ARNT but in the absence of AhR ligand or hypoxia we 
observed activation of AhR and HIF-1α function, as assessed by reporter gene assays 
(please see above). Immunostaining showed nuclear translocation of endogenous HIF 
1α. In agreement with these observations, upon ectopic expression of increasing levels 
of ARNT together with GFP-fused AhR or HIF-1α in COS cells, nuclear fluorescence 
can be observed. The subcellular localization of HIF-1α and ARNT was also 
determined by indirect immunofluorescence. The nuclei were stained with 4-6 diamino-
2-phenylindone (DAPI), and we show that the two bHLH –PAS proteins co-localize in 
the nuclear compartment of the cells, consistent with the activation of HIF-1α function 
under these conditions. 
 
 
CONCLUSIONS 
 
This work provides novel insights into how AhR signaling drives transcriptional 
programs via the ligand versus suspension modes of action. Following either route of 
AhR activation, AhR-specific target genes remained relatively small and included the 
classic xenobiotic metabolizing AhR targets such as Cyp1a1, Cyp1b1, and Nqo1. There 
were some differences in gene expression profiles between xenobiotic and suspension 
activated AhR signaling. Por, and Cldnd1 were regulated predominately by ligand 
treatments, while in contrast, ApoER2 and Ganc were regulated predominately by the 
suspension condition. Temporal expression patterns of AhR target genes were also 
found to vary, with examples of transient activation, transient repression, or sustained 
alterations in expression. 
 
The present data establish that an excess of ARNT can induce nuclear accumulation of 
the AhR and activate its function as a transcription factor in the absence of ligand. In a 
similar fashion, an excess of ARNT stabilized HIF-1α against proteasomal degradation 
in normoxia, induced its nuclear accumulation and activated its function as a 
transcription factor. Thus, these results indicate that modulation of the levels of ARNT 
or the size of the intracellular pool of ARNT available for dimerization with these 
partner proteins, may provide an alternative route of activation of these signaling 
pathways in the absence of environmental or hypoxic stress. 
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Inga Peculiene-the Lithuanian girl who really became the sunshine at CMB, for lovely 
discussions about science and life and everything that is important- and for helping out 
with experiments and always having time for a fika! 
Xiaofeng- for the trip to Lithuania. I will not forget that for a looong time !! 
Clas B Johansson- for special scrutiny in proofreading (and for mental support) of my 
thesis in the beginning-it was much needed ! 
 
New members of the lab; Michael Gralla for nice company and for always being 
friendly, Sarah Karttunen, - a very competent Aussie girl, who helped out with 
experiments, -thanks a lot for that, - it was fantastic!! Good Luck with your little 
Helena. 
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Nico Vojnovic for nice chats about science as well as life in general. 
Sandra Lücke- very nice post-doc who likes when things are arranged in a nice proper 
way.  
Administration with Zdravko and Irene who have everything running smoothly.  
Lisa Long for handling the mail and other important stuff and also the “dishwashing” 
ladies (Rosa-Amanda y Veronica) who always challenge my poor Spanish. Gracias 
por todo!! Hannele Jansson, Margaret Ulander – and the rest of the administrative 
staff, -who is taking care of everything for us with a smile !! 
 
People outside of science; 
Outside science I have a good friend in Katharina Ekbladh -we have taken the 
“studenten “together so we have known each other for a long time. For her generosity 
and life-wisdom! 
Rebecca Roy and Andreas Derblom and their two daughters, Tara and Selma, for 
friendship and lovely excursions into the wild- and for midsummer festivities as well as 
barbeque evenings in their garden-lovely!! 
Helena Upman  -a neighbor -she is the happiest of people- so much energy- thanks for 
the nice food and happy company!!  
More neighbors; Cecilia Östlund and her husband Björn as well as their sons Agaton 
and Milton -thanks for everything from rides to the airport to support exactly when I 
needed it- and for nice coffee breaks in the sun. Maria Wagenius and her significant 
other Hans Hall –my levelheaded neighbors-for nice chats and good coffee- and for 
being able to act calmly in stressed situations! 
 
And of course – my family -both the old one and the new one- I appreciate everything 
you have done for me………always! 
My parents Bo and RosMarie who are the solid ones I can always rely on -thanks! It 
does mean a lot……….even if I do not always say it, but it would not have been 
possible without, your endless support! 
This was especially apparent when I got sick, -you were both standing firm and did 
what you had to do…………Thanks for that again! 
My sister Anne Kallerhult –a real toughie if you have to, but also soft- a perfect 
combo!!  You are a diamond in the rough. 
Loka my niece-for being so cute all the time and for constantly asking questions 
(maybe you will become a scientist one day?) 
Johan- my sisters partner-for being generally nice (and at times really funny), and also 
very good for my sister. 
 
My sons Love and Leo – have had to go through a lot lately……….hopefully the trip 
will be smoother from now on. 
      I know you one day will be able to understand and hopefully also forgive!!  
 
                                       I love you both so much!! 
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